Therefore, we first used publicly available databases from human postmortem RNA-Seq studies to determine the cell type–specific expression of Kir6.2 (i.e., KCNJ11) and SUR1 (i.e., ABCC8) and how it changed across the AD continuum. This evidence concerns the gene KCNJ11 and Alzheimer disease.